Member Info for DeepFeckinValue

Hi Itacon, can you provide more detail?

Thordon, as long as the market values growth and that's reflected in the share price, I'll take that. But AIM isn't the best at valuing long term opportunities. I've always wondered whether JS would prefer a US listing given odd comments he has given here and there about US shareholders i.e. largely him and other ITX leadership. I actually wouln't be opposed to a US / dual listing, other than the costs this would bring, as nasdaq tends to value innovation, growth prospects and ESG credentials more so than AIM. Especially if it brough additional long term IIs like IP Group whose support has been unwavering and under appreciated imv.

DB, keen to know you're back of the envelope estimate of profitability? finnCapp seem to think this will be at £8m rev which we might reach towards the end of 23 / into 24. Felt a bit high to me, I might have guessed £6-7m, but I'm always too optimistic By that stage there will also be plenty of additional income sources starting to come online, I hope, e.g. BioAstrix / super absorbents / textiles?

finnCapp, in their company flash of 22 April, are not projecting another fund raise this year or next, as increasing sales increases working capital. Expecting to hold 0.4m cash this YE and 0.3m end FY23. I hadn't appreciated this. Feels like there is only upside to come.

2022 going to be a super strong year for ITX by the looks of it. Well done JS, clear that a lot of effort went into this preparation with nerves on show a bit more than usual, to me a nice sign highlighting how important he took this market update after a stalled 2021. Looking forward to hearing about growth in cleaning business and getting this to breakeven alongside hygiene business, successful outcome of super absorbent opps and new innovations being patented. Shame Bio Astrix is not to be a game changer soon, more a of longer burn opportunity. Also noted he said existing production capacity was 10m, I had always held 15m in my mind?

Catching up on the recent presentation and discussion topics here. At 6.50 during the presentation JS is talking about Helen, the Op's hire. He said that "...she has really taken command and increased the reliability of production here and some that we contract out..." then tails off as if he let slip. Any thoughts on this? I might guess we're licensing production to clients but JS has been clear in the past that we're a 'make and sell' business.

I expected a large sell to be reported late if there is this drop on £36k trades unfortunately

I'm sure the bright sleuths in here might be able to glean something from this supply chain site: importyeti.com/search?q=Itaconix&page=1

Just a question having been thinking about the FinnCAp appointment, and a comment in passing by JS on a recent webinar that a large % of shares are held in US hands. Is anyone aware of previous questions on this topic? A listing via a SPAC does not seem too far fetched. Some say US places more value on growth, but I wouldn't expect this to drive the SP on it's own but it couldn't hurt.

I think the reason that orders were met despite the flooding was prudent management of finished goods by JS and the Ops manager. (We seen a large amount on the balance sheet even last FY.)

But we know production was never running at 100%. Current production capacity is £15m I believe, and it would only take £0.5m to double this when we do reach this level. Hopefully we reach that sooner than later and the margin gain that would come alongside.

This was a really positive update and I agree with FoolsGold, it sets us up nicely for a trading update in Jan (although expect this to be in typical understated JS fashion, then surprise us all come full results). The share price was very oversold, another PI in the ADVFN board dumped c800k shares recently and I expect a lot of stop losses were triggers as a result. My view is that 10p is fair price currently which will hopefully rise on good 21 performance, and an update on Bio Astrix which will be a game changer. GLA